The edition · Geriatrics
Sarcopenia more than doubles the odds of poor stroke recovery, and dementia alone did not predict readmission after rehabilitation
A 36-study meta-analysis links sarcopenia to worse function after stroke, a Medicare-linked cohort finds that comorbidity and prior hospital use, not dementia, drive readmission after nursing-home rehabilitation, and a pilocarpine trial for dry mouth in frail patients is inconclusive.
The edition in brief
A meta-analysis of 36 cohort studies found stroke patients with sarcopenia had higher odds of poor global functional outcome on the modified Rankin Scale (OR 2.43, 95% CI 1.95 to 3.03) and lower motor and cognitive scores; swallowing dysfunction was raised but not significantly (OR 1.45, 0.94 to 2.25). In 4,527 discharges home after short nursing-home rehabilitation stays, 15.8% were readmitted within 30 days, and a dementia diagnosis was not associated with readmission, while prior hospital visits and higher comorbidity were. Across three ageing cohorts with 19,310 participants, dual hearing and vision impairment was associated with depressive symptoms (pooled OR 1.73), partly mediated by lower social engagement and cognitive decline. A double-blind trial of topical pilocarpine for dry mouth in 92 frail or life-limited adults found no significant difference in xerostomia severity and was underpowered. A systematic review of 11 studies found evidence on delirium recovery interventions limited and heterogeneous.
Readmission after nursing-home rehabilitation: prior hospital use and comorbidity matter more than dementia
When planning discharge after rehabilitation, flag patients with recent hospital use, high comorbidity and little home support for closer follow-up, whether or not they have dementia.
Hearing and vision loss together go with depressive symptoms across three countries
Ask about mood in older adults who have both hearing and vision difficulties, and check that glasses and hearing aids are in use.
Pilocarpine drops for dry mouth in frail and life-limited patients: no clear benefit in an underpowered trial
Pilocarpine drops are unproven for dry mouth in frail patients; a trial may be reasonable after simple measures have failed, with review of benefit at four weeks.
Delirium recovery: few trials, mostly in hospital, little on emotional recovery
Plan follow-up after delirium, covering memory, mood and function, even though no specific recovery intervention is proven.
Ask about hearing aids and glasses at every admission
Check at every admission that glasses and hearing aids are present and working.
Sarcopenia and stroke: poorer function and cognition, so assess muscle early
Consider screening older stroke patients for sarcopenia and involving nutrition and physiotherapy early, recognising that benefit of treating it has not been shown here.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for geriatrics, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free